• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型胸腔积液回声定量标志物在类肺炎性胸腔积液中的应用。

The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions.

机构信息

Respiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, Greece.

Louvain University Center for Sleep and Wake Disorders, Leuven, Belgium.

出版信息

Can Respir J. 2020 Oct 5;2020:1283590. doi: 10.1155/2020/1283590. eCollection 2020.

DOI:10.1155/2020/1283590
PMID:33082889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7556052/
Abstract

BACKGROUND

Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE.

METHODS

All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects.

RESULTS

Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH ( < 0.001,  = -0.831), pleural fluid glucose (=0.022,  = 0.474), and pleural fluid pH ( < 0.001,  = 0.811). HI was correlated with ADA levels (=0.005,  = -0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number ( < 0.001,  = -0.657) and polymorphonuclears percentage (=0.02,  = -0.590), as well as days to afebrile (=0.046,  = -0.411), duration of chest tube placement ( < 0.001,  = -0.806), and days of hospitalization (=0.013,  = -0.501). . HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE.

摘要

背景

在胸腔积液的日常临床护理中,尤其是在治疗类肺炎性胸腔积液(PPE)时,超声检查是一种必不可少的工具,可用于诊断、治疗和随访。低回声指数(HI)是胸腔积液回声强度的定量标志物。我们旨在研究 HI 与 PPE 患者胸腔炎症之间的关联。

方法

所有纳入的患者在 PPE 入院的第一天均进行了胸腔超声检查并测定 HI。所有患者均进行了胸腔穿刺术。所有患者均前瞻性地收集了人口统计学、实验室测量和临床数据,并记录在所有患者中。

结果

本研究共纳入 24 例 PPE 患者。HI 与胸腔积液 LDH(<0.001,r=-0.831)、胸腔积液葡萄糖(=0.022,r=0.474)和胸腔积液 pH(<0.001,r=0.811)提示的炎症强度呈统计学显著相关。HI 与 ADA 水平(=0.005,r=-0.552)相关。我们观察到 HI 与胸腔积液总细胞数(<0.001,r=-0.657)和多形核细胞百分比(=0.02,r=-0.590)呈统计学显著相关,与退热天数(=0.046,r=-0.411)、胸腔引流管放置时间(<0.001,r=-0.806)和住院时间(=0.013,r=-0.501)也呈统计学显著相关。

结论

HI 是一种快速、易于应用、客观和定量的胸腔炎症标志物,能够可靠地反映胸腔炎症的强度,可能有助于指导 PPE 的治疗管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/309cceb9c362/CRJ2020-1283590.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/a634ce124dc2/CRJ2020-1283590.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/161df397c830/CRJ2020-1283590.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/309cceb9c362/CRJ2020-1283590.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/a634ce124dc2/CRJ2020-1283590.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/161df397c830/CRJ2020-1283590.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067a/7556052/309cceb9c362/CRJ2020-1283590.003.jpg

相似文献

1
The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions.新型胸腔积液回声定量标志物在类肺炎性胸腔积液中的应用。
Can Respir J. 2020 Oct 5;2020:1283590. doi: 10.1155/2020/1283590. eCollection 2020.
2
Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.胸腔液中 suPAR 水平可预测类肺炎性胸腔积液患者是否需要有创性治疗。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1545-1553. doi: 10.1164/rccm.201911-2169OC.
3
Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.在首次胸腔穿刺时,将胸腔积液乳酸作为即时辅助诊断手段,以区分结核性和复杂性类肺炎性胸腔积液:在结核病流行地区的潜在应用。
Respir Investig. 2020 Sep;58(5):367-375. doi: 10.1016/j.resinv.2020.01.004. Epub 2020 Feb 24.
4
Parapneumonic effusions.肺炎旁胸腔积液
Am J Med. 1980 Oct;69(4):507-12. doi: 10.1016/0002-9343(80)90460-x.
5
Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.结核性胸腔积液中的非典型胸腔积液特征:与肺炎旁胸腔积液和恶性胸腔积液相比的序贯变化
Intern Med. 2016;55(13):1713-9. doi: 10.2169/internalmedicine.55.5803. Epub 2016 Jul 1.
6
Pleural effusions caused by infection.感染引起的胸腔积液。
Postgrad Med. 1986 Oct;80(5):213-6, 219, 222-3. doi: 10.1080/00325481.1986.11699570.
7
Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.用于鉴别以中性粒细胞为主且腺苷脱氨酶水平高的结核性和类肺炎性胸腔积液的胸腔积液腺苷脱氨酶/血清C反应蛋白比值
Infection. 2017 Feb;45(1):59-65. doi: 10.1007/s15010-016-0928-5. Epub 2016 Aug 3.
8
Pleural fluid cell-free DNA in parapneumonic pleural effusion.肺炎旁胸腔积液中的胸腔积液游离DNA
Clin Biochem. 2015 Oct;48(15):1003-5. doi: 10.1016/j.clinbiochem.2015.07.096. Epub 2015 Jul 31.
9
A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.一种利用胸腔CT上的胸膜分裂征和胸腔积液量来鉴别复杂性类肺炎性胸腔积液/脓胸与类肺炎性胸腔积液的简单方法。
PLoS One. 2015 Jun 15;10(6):e0130141. doi: 10.1371/journal.pone.0130141. eCollection 2015.
10
Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients.急性肺栓塞中胸腔积液的分析:230例患者的放射学和胸腔积液数据
Respirology. 2007 Mar;12(2):234-9. doi: 10.1111/j.1440-1843.2006.01026.x.

引用本文的文献

1
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review.胸膜疾病中的先进成像技术与人工智能:一篇叙述性综述
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0263-2024. Print 2025 Apr.
2
Advancing healthcare through thoracic ultrasound research in older patients.通过对老年患者的胸超声研究来推进医疗保健。
Aging Clin Exp Res. 2023 Dec;35(12):2887-2901. doi: 10.1007/s40520-023-02590-w. Epub 2023 Nov 11.
3
Effectiveness and Safety of Real-Time Transthoracic Ultrasound-Guided Thoracentesis.

本文引用的文献

1
Recent developments in the management of pleural infection: A comprehensive review.胸膜感染管理的最新进展:全面综述
Clin Respir J. 2018 Aug;12(8):2309-2320. doi: 10.1111/crj.12941.
2
CT versus thoracic ultrasound for discriminating uncomplicated and complicated parapneumonic pleural effusions.CT与胸部超声在鉴别单纯性和复杂性类肺炎性胸腔积液中的应用
Respirology. 2018 Feb;23(2):232. doi: 10.1111/resp.13204. Epub 2017 Oct 25.
3
Correlation of pleural effusions' grayscale sonographic parameters with fluid's analysis results.
实时经胸超声引导下胸腔穿刺术的有效性和安全性
Diagnostics (Basel). 2022 Mar 16;12(3):725. doi: 10.3390/diagnostics12030725.
4
Pleural Fluid Echogenicity Measured by Ultrasound Image Pixel Density to Differentiate Transudative versus Exudative Pleural Effusions.通过超声图像像素密度测量胸腔积液回声性以鉴别漏出液与渗出液性胸腔积液
Ann Am Thorac Soc. 2022 May;19(5):857-860. doi: 10.1513/AnnalsATS.202105-548RL.
5
Recent Insights into the Management of Pleural Infection.胸膜感染管理的最新见解
Int J Gen Med. 2021 Jul 14;14:3415-3429. doi: 10.2147/IJGM.S292705. eCollection 2021.
胸腔积液的灰阶超声参数与积液分析结果的相关性。
J Thorac Dis. 2017 Mar;9(3):543-546. doi: 10.21037/jtd.2017.03.31.
4
Ultrasound in the management of pleural disease.超声在胸膜疾病管理中的应用
Expert Rev Respir Med. 2017 Apr;11(4):323-331. doi: 10.1080/17476348.2017.1300531. Epub 2017 Mar 6.
5
Manual Intrapleural Saline Flushing Plus Urokinase: A Potentially Useful Therapy for Complicated Parapneumonic Effusions and Empyemas.手动胸腔内盐水冲洗加尿激酶:一种治疗复杂性类肺炎性胸腔积液和脓胸的潜在有效疗法。
Lung. 2017 Feb;195(1):135-138. doi: 10.1007/s00408-016-9964-2. Epub 2016 Nov 19.
6
The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions.胸膜超声检查在诊断复杂性类肺炎性胸腔积液中的准确性。
Thorax. 2017 Jan;72(1):94-95. doi: 10.1136/thoraxjnl-2016-208904. Epub 2016 Sep 9.
7
Pleural infection: past, present, and future directions.胸膜感染:过去、现在和未来的方向。
Lancet Respir Med. 2015 Jul;3(7):563-77. doi: 10.1016/S2213-2600(15)00185-X.
8
Management of parapneumonic effusions and empyema.肺炎旁胸腔积液和脓胸的管理
Semin Respir Crit Care Med. 2014 Dec;35(6):715-22. doi: 10.1055/s-0034-1395503. Epub 2014 Dec 2.
9
Can ultrasound guidance reduce the risk of pneumothorax following thoracentesis?超声引导能否降低胸腔穿刺后气胸的风险?
J Bras Pneumol. 2014 Jan-Feb;40(1):6-12. doi: 10.1590/S1806-37132014000100002.
10
New therapeutic approaches to pleural infection.胸膜感染的新治疗方法。
Curr Opin Infect Dis. 2013 Apr;26(2):196-202. doi: 10.1097/QCO.0b013e32835d0b71.